Pneumo 23 ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

pneumo 23

sanofi-aventis new zealand limited - pneumococcal polysaccharide serotype 1 25ug; pneumococcal polysaccharide serotype 10a 25ug; pneumococcal polysaccharide serotype 11a 25ug; pneumococcal polysaccharide serotype 12f 25ug; pneumococcal polysaccharide serotype 14 25ug; pneumococcal polysaccharide serotype 15b 25ug; pneumococcal polysaccharide serotype 17f 25ug; pneumococcal polysaccharide serotype 18c 25ug; pneumococcal polysaccharide serotype 19a 25ug; pneumococcal polysaccharide serotype 19f 25ug; pneumococcal polysaccharide serotype 2 25ug; pneumococcal polysaccharide serotype 20 25ug; pneumococcal polysaccharide serotype 22f 25ug; pneumococcal polysaccharide serotype 23f 25ug; pneumococcal polysaccharide serotype 3 25ug; pneumococcal polysaccharide serotype 33f 25ug; pneumococcal polysaccharide serotype 4 25ug; pneumococcal polysaccharide serotype 5 25ug; pneumococcal polysaccharide serotype 6b 25ug; pneumococcal polysaccharide serotype 7f 25ug; pneumococcal polysaccharide serotype 8 25ug; pneumococcal polysaccharide serotype 9n 25ug; pneumococcal polysaccharide serotype 9v 25ug - suspension for injection - 25 mcg - active: pneumococcal polysaccharide serotype 1 25ug pneumococcal polysaccharide serotype 10a 25ug pneumococcal polysaccharide serotype 11a 25ug pneumococcal polysaccharide serotype 12f 25ug pneumococcal polysaccharide serotype 14 25ug pneumococcal polysaccharide serotype 15b 25ug pneumococcal polysaccharide serotype 17f 25ug pneumococcal polysaccharide serotype 18c 25ug pneumococcal polysaccharide serotype 19a 25ug pneumococcal polysaccharide serotype 19f 25ug pneumococcal polysaccharide serotype 2 25ug pneumococcal polysaccharide serotype 20 25ug pneumococcal polysaccharide serotype 22f 25ug pneumococcal polysaccharide serotype 23f 25ug pneumococcal polysaccharide serotype 3 25ug pneumococcal polysaccharide serotype 33f 25ug pneumococcal polysaccharide serotype 4 25ug pneumococcal polysaccharide serotype 5 25ug pneumococcal polysaccharide serotype 6b 25ug pneumococcal polysaccharide serotype 7f 25ug pneumococcal polysaccharide serotype 8 25ug pneumococcal polysaccharide serotype 9n 25ug pneumococcal polysaccharide serotype 9v 25ug excipient: dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate phenol sodium chloride water for injection - pneumo 23 is indicated for high risk subjects 2 years of age and above to prevent pneumococcal pneumonia and systemic pneumococcal infections caused by the serotypes included in the vaccine.

Pneumococcal polysaccharide vaccine Sanofi Pasteur MSD solution for injection in a vial מלטה - אנגלית - Malta Medicines Authority

pneumococcal polysaccharide vaccine sanofi pasteur msd solution for injection in a vial

central procurement & supplies unit - pneumococcal polysaccharide, serotype, f conjugated, to crm - solution for injection - pneumococcal polysaccharide serotype 23f conjugated to crm197 25 microgram(s) - vaccines

Pneumococcal Polysaccharide Vaccine Solution for Injection 25mcg/0.5ml מלטה - אנגלית - Malta Medicines Authority

pneumococcal polysaccharide vaccine solution for injection 25mcg/0.5ml

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - pneumococcal polysaccharide, serotype, conjugated to, crm, b conjugated, to crm, f conjugated, n conjugated, v conjugated, a conjugated, c conjugated - solution for injection - pneumococcal polysaccharide serotype 1 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 2 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 3 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 4 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 5 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 6b conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 7f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 8 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 9n conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 9v conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 10a conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 11a conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 12f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 14 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 15b conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 17f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 18c conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 19f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 19a conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 19f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 20 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 22f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 23f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 33f conjugated to crm197 50 µg/ml - vaccines

Pneumo 23 (Polysaccharide pneumococcal vaccine) Solution For Injection In Pre-Filled Syringe קניה - אנגלית - Pharmacy and Poisons Board

pneumo 23 (polysaccharide pneumococcal vaccine) solution for injection in pre-filled syringe

sanofi pasteur s.a. 2 avenue pont pasteur 69007 lyon - polysaccharides of streptococcus pneumonia… - solution for injection in pre-filled syringe - one dose of 0.5 ml contains: polysaccharides of… - bacterial vaccines: pneumococcal vaccines

PNEUMOVAX 23     -(5-DOSE) SOLUTION קנדה - אנגלית - Health Canada

pneumovax 23 -(5-dose) solution

merck canada inc - pneumococcal vaccine polyvalent - solution - 25mcg - pneumococcal vaccine polyvalent 25mcg - vaccines

Prevenar האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

prevenar

pfizer limited - pneumococcal oligosaccharide serotype 18c, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 14 - pneumococcal infections; immunization - vaccines - active immunisation against disease caused by streptococcus pneumoniae serotypes 4, 6b, 9v, 14, 18c, 19f and 23f (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media) in infants and children from two months up to five years of age.the use of prevenar should be determined on the basis of official recommendations taking into consideration the impact of invasive disease in different age groups as well as variability of serotype epidemiology in different geographical areas.

Apexxnar האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

apexxnar

pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - pneumococcal infections - vaccines - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older.see sections 4.4 and 5.1 for information on protection against specific pneumococcal serotypes.apexxnar should be used in accordance with official recommendations.